CN111455021A - 去除宏基因组中宿主dna的方法及试剂盒 - Google Patents
去除宏基因组中宿主dna的方法及试剂盒 Download PDFInfo
- Publication number
- CN111455021A CN111455021A CN201910047978.6A CN201910047978A CN111455021A CN 111455021 A CN111455021 A CN 111455021A CN 201910047978 A CN201910047978 A CN 201910047978A CN 111455021 A CN111455021 A CN 111455021A
- Authority
- CN
- China
- Prior art keywords
- magnetic beads
- dna
- metagenome
- host dna
- host
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 60
- 239000011324 bead Substances 0.000 claims abstract description 86
- 239000012634 fragment Substances 0.000 claims abstract description 29
- 238000009396 hybridization Methods 0.000 claims abstract description 24
- 238000005576 amination reaction Methods 0.000 claims abstract description 22
- 238000005859 coupling reaction Methods 0.000 claims abstract description 22
- 230000008878 coupling Effects 0.000 claims abstract description 20
- 238000010168 coupling process Methods 0.000 claims abstract description 20
- 239000006228 supernatant Substances 0.000 claims abstract description 17
- 238000013467 fragmentation Methods 0.000 claims abstract description 16
- 238000006062 fragmentation reaction Methods 0.000 claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 239000012530 fluid Substances 0.000 claims abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 28
- 230000000903 blocking effect Effects 0.000 claims description 21
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 16
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 9
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 8
- 238000004925 denaturation Methods 0.000 claims description 8
- 230000036425 denaturation Effects 0.000 claims description 8
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 8
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 8
- 239000001103 potassium chloride Substances 0.000 claims description 8
- 235000011164 potassium chloride Nutrition 0.000 claims description 8
- 230000004913 activation Effects 0.000 claims description 7
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 238000002525 ultrasonication Methods 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 claims description 3
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 abstract description 22
- 102000039446 nucleic acids Human genes 0.000 abstract description 22
- 150000007523 nucleic acids Chemical class 0.000 abstract description 22
- 244000000010 microbial pathogen Species 0.000 abstract description 12
- 238000001514 detection method Methods 0.000 abstract description 11
- 108700005443 Microbial Genes Proteins 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 99
- 239000000523 sample Substances 0.000 description 48
- 238000012163 sequencing technique Methods 0.000 description 31
- 239000000243 solution Substances 0.000 description 14
- 244000005700 microbiome Species 0.000 description 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 8
- GUAHPAJOXVYFON-ZETCQYMHSA-N (8S)-8-amino-7-oxononanoic acid zwitterion Chemical compound C[C@H](N)C(=O)CCCCCC(O)=O GUAHPAJOXVYFON-ZETCQYMHSA-N 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 241000588832 Bordetella pertussis Species 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 208000035473 Communicable disease Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000012165 high-throughput sequencing Methods 0.000 description 3
- 210000005260 human cell Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- MIIIXQJBDGSIKL-UHFFFAOYSA-N 2-morpholin-4-ylethanesulfonic acid;hydrate Chemical compound O.OS(=O)(=O)CCN1CCOCC1 MIIIXQJBDGSIKL-UHFFFAOYSA-N 0.000 description 2
- 108020003215 DNA Probes Proteins 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- RWYHOIUBWBDNSP-UHFFFAOYSA-N 1-oxidanylpyrrolidine-2,5-dione Chemical compound ON1C(=O)CCC1=O.ON1C(=O)CCC1=O RWYHOIUBWBDNSP-UHFFFAOYSA-N 0.000 description 1
- 208000010370 Adenoviridae Infections Diseases 0.000 description 1
- 206010060931 Adenovirus infection Diseases 0.000 description 1
- 241000499489 Castor canadensis Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 201000003838 Idiopathic interstitial pneumonia Diseases 0.000 description 1
- 206010061259 Klebsiella infection Diseases 0.000 description 1
- 235000011779 Menyanthes trifoliata Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000011589 adenoviridae infectious disease Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- -1 azide propidium iodide Chemical class 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
参数 | 设定值 |
Peak Power(峰值功率) | 50W |
Duty Factor(脉冲占空系数) | 20.0 |
Cycles/Burst(循环数) | 200 |
Time(时间) | 300s |
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910047978.6A CN111455021B (zh) | 2019-01-18 | 去除宏基因组中宿主dna的方法及试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910047978.6A CN111455021B (zh) | 2019-01-18 | 去除宏基因组中宿主dna的方法及试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111455021A true CN111455021A (zh) | 2020-07-28 |
CN111455021B CN111455021B (zh) | 2024-06-04 |
Family
ID=
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009069843A1 (en) * | 2007-11-30 | 2009-06-04 | Korea Research Institute Of Bioscience And Biotechnology | Methods for fabrication of metagenomes microarrays and quantitative detection of genes or microorganisms using metagenomes microarrays |
CN101701252A (zh) * | 2009-11-20 | 2010-05-05 | 吉林大学 | 一种快速检测牛奶中金黄色葡萄球菌的试剂盒 |
CN102839168A (zh) * | 2012-07-31 | 2012-12-26 | 深圳华大基因研究院 | 核酸探针及其制备方法和应用 |
CN103060309A (zh) * | 2012-09-25 | 2013-04-24 | 中国科学院北京基因组研究所 | 宏基因组提取方法 |
CN103602658A (zh) * | 2013-10-15 | 2014-02-26 | 东南大学 | 一种新型靶向核酸分子的捕获与富集技术 |
CN104039982A (zh) * | 2012-08-01 | 2014-09-10 | 深圳华大基因研究院 | 一种分析微生物群落组成的方法和装置 |
US20150232834A1 (en) * | 2014-02-15 | 2015-08-20 | The Board Of Trustees Of The Leland Stanford Junior University | Partitioning of dna sequencing libraries into host and microbial components |
US20150360194A1 (en) * | 2013-05-04 | 2015-12-17 | The Board Of Trustees Of The Leland Stanford Junior University | Enrichment of DNA Sequencing Libraries from Samples Containing Small Amounts of Target DNA |
US20160160275A1 (en) * | 2013-07-19 | 2016-06-09 | Ludwig Institute For Cencer Research | Whole-genome and targeted haplotype reconstruction |
CN106148326A (zh) * | 2016-07-27 | 2016-11-23 | 上海美吉生物医药科技有限公司 | 宏基因组dna的提取方法 |
CN106661625A (zh) * | 2014-07-10 | 2017-05-10 | 动力生物科学有限公司 | 检测不存在微生物的方法和试剂盒 |
WO2018053308A1 (en) * | 2016-09-15 | 2018-03-22 | Sun Genomics Llc | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
CN108048450A (zh) * | 2017-12-21 | 2018-05-18 | 广州赛哲生物科技股份有限公司 | 一种痰液微生物宏基因组去宿主化提取和建库方法 |
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009069843A1 (en) * | 2007-11-30 | 2009-06-04 | Korea Research Institute Of Bioscience And Biotechnology | Methods for fabrication of metagenomes microarrays and quantitative detection of genes or microorganisms using metagenomes microarrays |
CN101701252A (zh) * | 2009-11-20 | 2010-05-05 | 吉林大学 | 一种快速检测牛奶中金黄色葡萄球菌的试剂盒 |
CN102839168A (zh) * | 2012-07-31 | 2012-12-26 | 深圳华大基因研究院 | 核酸探针及其制备方法和应用 |
CN104039982A (zh) * | 2012-08-01 | 2014-09-10 | 深圳华大基因研究院 | 一种分析微生物群落组成的方法和装置 |
CN103060309A (zh) * | 2012-09-25 | 2013-04-24 | 中国科学院北京基因组研究所 | 宏基因组提取方法 |
US20150360194A1 (en) * | 2013-05-04 | 2015-12-17 | The Board Of Trustees Of The Leland Stanford Junior University | Enrichment of DNA Sequencing Libraries from Samples Containing Small Amounts of Target DNA |
US20160160275A1 (en) * | 2013-07-19 | 2016-06-09 | Ludwig Institute For Cencer Research | Whole-genome and targeted haplotype reconstruction |
CN103602658A (zh) * | 2013-10-15 | 2014-02-26 | 东南大学 | 一种新型靶向核酸分子的捕获与富集技术 |
US20150232834A1 (en) * | 2014-02-15 | 2015-08-20 | The Board Of Trustees Of The Leland Stanford Junior University | Partitioning of dna sequencing libraries into host and microbial components |
CN106661625A (zh) * | 2014-07-10 | 2017-05-10 | 动力生物科学有限公司 | 检测不存在微生物的方法和试剂盒 |
CN106148326A (zh) * | 2016-07-27 | 2016-11-23 | 上海美吉生物医药科技有限公司 | 宏基因组dna的提取方法 |
WO2018053308A1 (en) * | 2016-09-15 | 2018-03-22 | Sun Genomics Llc | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
CN108048450A (zh) * | 2017-12-21 | 2018-05-18 | 广州赛哲生物科技股份有限公司 | 一种痰液微生物宏基因组去宿主化提取和建库方法 |
Non-Patent Citations (4)
Title |
---|
ERBAY YIGIT等: "A Microbiome DNA Enrichment Method UNIT 7.26 for Next-Generation Sequencing Sample Preparation", CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, pages 1 - 14 * |
GONG等: "Culture-independent analysis of liver abscess using nanopore sequencing", PLOS ON, vol. 13, no. 1, 31 December 2018 (2018-12-31), pages 1 - 11 * |
徐利军;王晓泉;刘秀梵;: "兽医领域病毒宏基因组非序列依赖性单引物扩增方法的研究现状", 中国家禽, no. 12, pages 5 - 8 * |
翟玉龙;李德洋;杜小红;何显力;邢金良;: "一种新的线粒体基因组DNA捕获探针的制备及初步应用", 现代生物医学进展, no. 13, 10 May 2016 (2016-05-10), pages 2459 - 2445 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7408229B2 (ja) | ポリヌクレオチド捕捉材料およびその使用方法 | |
US20060078923A1 (en) | Method for isolating nucleic acids | |
CN108410951B (zh) | 一种新的核酸提取试剂及其应用 | |
JP2008510456A (ja) | 多官能基コート化固相担体を用いる核酸の単離方法 | |
CN112159835B (zh) | 一种通过探针捕获富集核酸的方法 | |
CN108026570A (zh) | 从血液样品中纯化核酸的组合物和方法 | |
CN111961713A (zh) | 用于遗传病致病基因携带者筛查的探针组合物、试剂盒及其制备方法 | |
CN107858357B (zh) | 牛呼吸道合胞体g蛋白特异性核酸适配体 | |
CN112481254B (zh) | 一步法去宿主dna并富集微生物的方法及试剂盒 | |
JP2021518157A (ja) | 核酸を抽出するための方法 | |
CN111500583B (zh) | 特异性识别牛妊娠相关糖蛋白4的核酸适配体及其应用 | |
JP2021104046A (ja) | ホルムアルデヒドを含有する液体系細胞診用保存剤中検体から核酸を単離する方法 | |
CA2498951A1 (en) | Method for enriching procaryotic dna | |
CN110088282A (zh) | 用磁性颗粒分离高纯度核酸的方法 | |
CN111455021A (zh) | 去除宏基因组中宿主dna的方法及试剂盒 | |
CN111455021B (zh) | 去除宏基因组中宿主dna的方法及试剂盒 | |
CN116024321B (zh) | 一种鉴定植物体内转录因子结合位点的方法及应用 | |
CN111334511B (zh) | 一种特异性识别牛妊娠相关糖蛋白的核酸适配体及其应用 | |
WO2020118543A1 (zh) | 分离和/或富集宿主源核酸和病原核酸的方法和试剂及其制备方法 | |
CN106283198B (zh) | 用于单细胞全基因组重亚硫酸氢盐测序的文库构建方法 | |
CN114032243B (zh) | 特异性结合环丙沙星的核酸适配体及其用途 | |
CN112575097B (zh) | 一种用于检测蜡样芽孢杆菌的液相芯片及应用 | |
CN116162690B (zh) | 一管式靶向高通量测序方法 | |
CN114214390B (zh) | 用于高通量测序的微生物饲料添加剂的核酸提取方法 | |
CN114231526B (zh) | 一种高丰度粪便微生物基因组dna提取的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201010 Address after: 510130 No. 301, building G10, South China new material innovation park, self compiled building 3, No. 31, Kefeng Road, Guangzhou high tech Industrial Development Zone, Guangdong Province Applicant after: Guangzhou Weiyuan Medical Equipment Co.,Ltd. Applicant after: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd. Applicant after: Guangzhou Weiyuan medical laboratory Co.,Ltd. Applicant after: Shenzhen Weiyuan Medical Technology Co.,Ltd. Applicant after: Weiyuan (Shenzhen) Medical Research Center Co.,Ltd. Address before: 510130 Three South China New Materials Innovation Park G10 Building 303, No. 31 Kefeng Road, Guangzhou High-tech Industrial Development Zone, Guangdong Province Applicant before: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230821 Address after: Room 301, G10, South China new material innovation park, building 3, No. 31, Kefeng Road, Guangzhou hi tech Industrial Development Zone, Guangdong 510130 Applicant after: Guangzhou Weiyuan Medical Equipment Co.,Ltd. Applicant after: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd. Applicant after: Guangzhou Weiyuan medical laboratory Co.,Ltd. Applicant after: Shenzhen Weiyuan Medical Technology Co.,Ltd. Address before: Room 301, G10, South China new material innovation park, building 3, No. 31, Kefeng Road, Guangzhou hi tech Industrial Development Zone, Guangdong 510130 Applicant before: Guangzhou Weiyuan Medical Equipment Co.,Ltd. Applicant before: GUANGZHOU VISION GENE TECHNOLOGY Co.,Ltd. Applicant before: Guangzhou Weiyuan medical laboratory Co.,Ltd. Applicant before: Shenzhen Weiyuan Medical Technology Co.,Ltd. Applicant before: Weiyuan (Shenzhen) Medical Research Center Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant |